GSTC — GlobeStar Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for GlobeStar Therapeutics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.1	0.081	0.006	0.006	0
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.141	0.089	0.006	0.01	0
Net Property, Plant And Equipment	0.001	0.001	0	—	—
Net Intangible Assets
Long Term Investments
Total Assets	0.142	0.09	0.006	0.01	0
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.828	0.749	0.732	1.2	1.43
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.828	0.749	0.732	1.2	1.43
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.685	-0.659	-0.726	-1.19	-1.43
Total Liabilities & Shareholders' Equity	0.142	0.09	0.006	0.01	0
Total Common Shares Outstanding
Total Preferred Shares Outstanding